This complimentary webinar (Dec. 15, 6 pm CET) brings together thought leaders for a candid discussion of the implications of different approaches to managing industry/academic relationships on the enterprise of drug development.
Stakeholders from the industry, academia and government will share perspectives to advance the mutual understanding of all parties of the impact different policies will have on their respective missions.
Click here to register - for free!
Key questions include:
- Is the for-profit nature of pharmaceutical companies compatible with the principles of scientific research?
- Is there such a thing as “conflict-free” research?
- How can or will the government police conflicts, especially in the context of the advisory committee process?
Speakers include:
- Steve Nissen, Chairman, Department of Cardiovascular Medicine Cleveland Clinic Foundation and Professor of Medicine at Case Western Reserve University
- Jill Hartzler Warner, Acting Associate Commissioner for Special Programs Office of the Commissioner, U.S. FDA
- Freda C. Lewis-Hall, Senior Vice President and Chief Medical Officer, Pfizer
- Michael Weber, Professor of Medicine and Associate Dean for Research, SUNY Downstate College of Medicine
Attendees will hear different perspectives on the appropriate methods for collaborative research and the implications of different potential policies to mitigate or eliminate conflict-of-interest.
Click here to register - for free!
